Quantification of hepatitis B virus genomes and infectivity in human serum samples

Transfusion

Volumn 46, Issue 10, 2006, Pages 1829-1835

  Hsia, Chu Chieh ^a   Purcell, Robert H ^a   Farshid, Mahmood ^a   Lachenbruch, Peter A ^a   Yu, Mei Ying W ^a  

^a HFM 310 ^*

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADR GENE; ADW GENE; ARTICLE; AYW GENE; DILUTION; DNA EXTRACTION; DNA SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; NESTED POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SERUM; VIRUS CARRIER; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS TITRATION;

ANIMALS; DNA, VIRAL; GENES, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; PAN TROGLODYTES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM; SPECIES SPECIFICITY;

EID: 33748948790     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00974.x     Document Type: Article

References (44)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion transmitted viral infections. N Engl J Med 1996;334:1685-90.
2. Dodd RY, Notari IV, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002;42:975-9.
3. Coste J, Reesink HW, Engelfriet CP, et al. International Forum: Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang 2005;88:289-303.
4. Koppelman MH, Assal A, Chudy M, et al. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005;45:1258-66.
5. Kleinman SH, Strong DM, Tegtmeier GGE, et al. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005;45:1247-57.
6. Biswas R, Tabor E, Hsia CC, et al. Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion 2003;43:788-98.
7. Stramer SL. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not [editorial]. Transfusion 2005;45:1242-6.
8. Barker LF, Maynard JE, Purcell RH, et al. Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis 1975;132:451-8.
9. Tabor E, Purcell RH, London WT, Gerety RJ. Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis 1983;147:531-4.
10. Saldanha J, Gerlich W, Lelie N, et al. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001;80:63-71.
11. Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America. J Med Virol 2003;70:20-6.
12. Norder H, Hammas B, Löfdahl S, et al. Comparison of the amino acid sequences of nine different serotytpes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 1992;73:1201-8.
13. Norder H, Couroucé AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004;47:289-309.
14. Weinberger KM, Wiedenmann E, Böhm S, Jilg W. Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system. J Virol Methods 2000;85:75-82.
15. Hawkes RA. General principles underlying laboratory diagnosis of viral infections. In: Lennette EH, Schmidt NJ, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections. 5th ed. Washington (DC): American Public Health Association; 1979. p. 32-5.
16. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S gene. Intervirology 1995;38:24-34.
17. Couroucé AM, Placon A, Soulier JP. Distribution of HBsAg subtypes in the world. Vox Sang 1983;44:197-211.
18. Stuyer L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74.
19. Arauz-Ruiz P, Norder H, Robertson BH, Margnius LO, Genotype H. a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002;83:2059-73.
20. Berninger M, Hammer M, Hoyer B, Gerlin JL. An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol 1982;9:57-68.
21. Ulrich PP, Bhat RA, Seto B, et al. Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis 1989;160:37-43.
22. Hendricks DA, Stowe BJ, Hoo BS, et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 1995;104:537-46.
23. Kao JH, Wood M, Chen PJ, et al. Comparison of two methods for quantification of hepatitis B viral DNA. J Gastroenterol Hepatol 1999;14:423-6.
24. Nolte FS. Branched DNA signal amplification for direct quantitation of nucleic acid sequences in clinical specimens. Adv Clin Chem 1998;33:201-35.
25. De Lamballerie X, Gallian P, De Micco PH. Evaluation of a chemiluminescent molecular hybridization assay for the detection and quantitation of hepatitis B virus-DNA in serum. New Microbiol 1995;18:207-13.
26. Kessler HH, Pierer K, Dragon E, et al. Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin Diagn Virol 1998;9:37-43.
27. Lopez VA, Bourne EJ, Lutz MW, Condreay LD. Assessment of the COBAS Amplicor HBV Monitor test for quantitation of serum hepatitis B virus DNA levels. J Clin Microbiol 2002;40:1972-6.
28. Ying C, Van Pelt J, Yap SH, et al. Use of digoxigenin-labelled probes for the quantitation of HBV-DNA in antiviral drug evaluation. J Virol Methods 1999;81:155-8.
29. Defoort JP, Martin M, Casano B, et al. Simultaneous detection of multiplex-amplified human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA using a flow cytometer microsphere-based hybridization assay. J Clin Microbiol 2000;38:1066-71.
30. Payan C, Veal N, Crescenzo-Chaigne B, et al. New quantitative assay of hepatitis B and C viruses by competitive PCR using alternative internal sequences. J Virol Methods 1997;65:299-305.
31. Simpson PR, Yu XH, Redza ZM, et al. Quantification of hepatitis B virus DNA using competitive PCR and a scintillation proximity assay. J Virol Methods 1997;69:197-208.
32. Chetverina HV, Samatov TR, Ugarov VI, Chetverin AB. Molecular colony diagnostics: detection and quantitation of viral nucleic acids by in-gel PCR. Biotechniques 2002;33:150-2,154,156.
33. Abe A, Inoue K, Tanaka T, et al. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 1999;37:2899-903.
34. Mercier B, Burlot L, Férec C. Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay. J Virol Methods 1999;77:1-9.
35. Saito T, Shinzawa H, Uchida T, et al. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol 1999;58:325-31.
36. Chen RW, Piiparinen H, Seppanen M, et al. Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol 2001;65:250-6.
37. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36:1408-15.
38. Loeb KR, Jerome KR, Goddard J, et al. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000;32:626-9.
39. Paraskevis D, Haida C, Tassopoulos N, et al. Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods 2002;103:201-12.
40. Zanella I, Rossini A, Domenighini D, et al. Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma. J Med Virol 2002;68:494-9.
41. Gripon P, Rumin S, Urban S, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002;99:15655-60.
42. Gripon P, Cannie I, Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 2005;79:1613-22.
43. Yugi H, Mizui M, Tanaka J, Yoshizawa H. Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. J Clin Virol 2006;36(Suppl 1):S56-64.
44. Cote PJ, Korba BE, Miller RH, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 2000;31:190-200.